CELESTIA: Cost-Effectiveness Analysis of Empagliflozin Versus Sitagliptin in Patients with Type 2 Diabetes in Greece
Gianni Ghetti,1 Lorenzo Pradelli,1 Giannis Papageorgiou,2 George Karpouzos,2 Yelda Arikan3 1AdRes Health Economics and Outcome Research, Turin, Italy; 2Boehringer Ingelheim Hellas, Athens, Greece; 3Boehringer Ingelheim, Amsterdam, the NetherlandsCorrespondence: Gianni Ghetti, AdRes Health Economics...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Book |
| Published: |
Dove Medical Press,
2023-02-01T00:00:00Z.
|
| Subjects: | |
| Online Access: | Connect to this object online. |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Internet
Connect to this object online.3rd Floor Main Library
| Call Number: |
A1234.567 |
|---|---|
| Copy 1 | Available |